The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Journal: Evidence-based Cardiology. 2017;10(3): 23‑26

Read: 805 times

To cite this article:

. Evidence-based Cardiology. 2017;10(3):23‑26. (In Russ.)

References:

  1. Schoenfeld A.J., Grady D. Adverse effects associated with proton pump inhibitors. JAMA Intern Med 2016;176:172—174.
  2. Xie Y., Bowe B., Li T., et al. Proton pump inhibitors and risk of incident CKD and progression to ESRD. J Am Soc Nephrol 2016;27:3153—3163.
  3. Antoniou T., Macdonald E.M., Hollands S., et al. Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort study. CMAJ Open 2015;3:E166—E171.
  4. Klepser D.G., Collier D.S., Cochran G.L. Proton pump inhibitors and acute kidney injury: a nested case-control study. BMC Nephrol 2013;14:150.
  5. Blank M.L., Parkin L., Paul C., et al. A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use. Kidney Int 2014;86:837—844.
  6. Lazarus B., Chen Y., Wilson F.P., et al. Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med 2016;176:238—246.
  7. Xie Y., Bowe B., Li T., et al. Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury. Kidney Int 2017;91:1482—1494.
  8. Gomm W., von Holt K., Thomé F., et al. Association of proton pump inhibitors with risk of dementia: a pharmacoepidemiological claims data analysis. JAMA Neurol 2016;73:410—416.
  9. Danziger J., William J.H., Scott D.J., et al. Proton-pump inhibitor use is associated with low serum magnesium concentrations. Kidney Int 2013;83:692—699.
  10. Kieboom B.C., Kiefte-de Jong J.C., Eijgelsheim M., et al. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study. Am J Kidney Dis 2015;66:775—782.
  11. Broeren M.A., Geerdink E.A., Vader H.L., et al. Hypomagnesemia induced by several proton-pump inhibitors. Ann Intern Med 2009;151:755—756.
  12. Kwok C.S., Arthur A.K., Anibueze C.I., et al. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol 2012;107:1011—1019.
  13. Zhou B., Huang Y., Li H., et al. Proton-pump inhibitors and risk of fractures: an update meta-analysis. Osteoporos Int 2016;27:339—347.
  14. Yu E.W., Bauer S.R., Bain P.A., et al. Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies. Am J Med 2011;124:519—526.
  15. Melloni C., Washam J.B., Jones W.S., et al. Conflicting results between randomized trials and observational studies on the impact of proton pump inhibitors on cardiovascular events when coadministered with dual antiplatelet therapy: systematic review. Circ Cardiovasc Qual Outcomes 2015;8:47—55.
  16. Filion K.B., Chateau D., Targownik L.E., et al. Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis. Gut 2014;63:552—558.
  17. Eom C.S., Jeon C.Y., Lim J.W., et al. Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis. CMAJ 2011;183:310—319.
  18. Yepuri G., Sukhovershin R., Nazari-Shafti T.Z., et al. Proton pump inhibitors accelerate inhibitors endothelial senescence. Circ Res 2016;118.
  19. Bell J.S., Strandberg T.E., Teramura-Gronblad M., et al. Use of proton pump inhibitors and mortality among institutionalized older people. Arch Intern Med 2010;170:1604—1605.
  20. Maggio M., Corsonello A., Ceda G.P., et al. Proton pump inhibitors and risk of 1-year mortality and rehospitalization in older patients discharged from acute care hospitals. JAMA Intern Med 2013;173:518—523.
  21. Teramura-Grönblad M., Bell J.S., Pöysti M.M., et al. Risk of death associated with use of PPIs in three cohorts of institutionalized older people in Finland. J Am Med Dir Assoc 2012;13:488.e9—e13.
  22. Wilson N., Gnjidic D., March L., et al. Use of PPIs are not associated with mortality in institutionalized older people. Arch Intern Med 2011;171:866.
  23. Forgacs I., Loganayagam A. Overprescribing proton pump inhibitors. BMJ 2008;336:2—3.
  24. Choudhry M.N., Soran H., Ziglam H.M. Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease. QJM 2008;101:445—448.
  25. Zink D.A., Pohlman M., Barnes M., et al. Long-term use of acid suppression started inappropriately during hospitalization. Aliment Pharmacol Ther 2005;21:1203—1209.
  26. Strid H., Simren M., Bjornsson E.S. Overuse of acid suppressant drugs in patients with chronic renal failure. Nephrology, dialysis, transplantation: of cial publication of the European Dialysis and Transplant Association — European Renal Association. Nephrol Dial Transplant 2003;18:570—575.
  27. Qato D.M., Alexander G.C., Conti RM, et al. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA 2008;300:2867—2878.
  28. Kantor E.D., Rehm C.D., Haas J.S., et al. Trends in prescription drug use among adults in the United States from 1999-2012. JAMA 2015;314:1818—1831.
  29. Katz M.H. Failing the acid test: benefits of proton pump inhibitors may not justify the risks for many users. Arch Intern Med 2010;170:747—748.
  30. Linsky A., Simon S.R. Reversing gears: discontinuing medication therapy to prevent adverse events. JAMA Intern Med 2013;173:524—525.
  31. Grady D., Redberg R.F. Less is more: how less health care can result in better health. Arch Intern Med 2010;170:749—750.
  32. Yachimski P.S., Farrell E.A., Hunt D.P., et al. Proton pump inhibitors for prophylaxis of nosocomial upper gastrointestinal tract bleeding: effect of standardized guidelines on prescribing practice. Arch Intern Med 2010;170:779—783.
  33. Kucuk H.F., Akyol H., Kaptanoglu L., et al. Effect of proton pump inhibitors on hepatic regeneration. Eur Surg Res 2006;38:322—328.
  34. Becker J.C., Grosser N., Waltke C., et al. Beyond gastric acid reduction: proton pump inhibitors induce heme oxygenase-1 in gastric and endothelial cells. Biochem Biophys Res Commun 2006;345:1014—1021.
  35. Nath K.A. Heme oxygenase-1 and acute kidney injury. Curr Opin Nephrol Hypertens 2014;23:17—24.
  36. Wu D., Qiu T., Zhang Q., et al. Systematic toxicity mechanism analysis of proton pump inhibitors: an in Silico Study. Chem Res Toxicol 2015;28:419—430.
  37. Liu W., Baker S.S., Trinidad J., et al. Inhibition of lysosomal enzyme activities by proton pump inhibitors. J Gastroenterol 2013;48:1343—1352.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.